Tuesday, October 14, 2025
  • Advertise
  • Recruitment
  • Contact us:
  • Register
Irish Pharmacy News
  • News
    • Latest
    • Community Pharmacy
  • Learning
    • CPD
    • Features
    • Team Training
    • Research
  • Magazines
  • OTC
    • OTC Awards
    • Product News
  • Awards
    • Irish Pharmacy Awards 2024
    • Awards News
  • HPN
  • Log In
  • Register
No Result
View All Result
  • News
    • Latest
    • Community Pharmacy
  • Learning
    • CPD
    • Features
    • Team Training
    • Research
  • Magazines
  • OTC
    • OTC Awards
    • Product News
  • Awards
    • Irish Pharmacy Awards 2024
    • Awards News
  • HPN
  • Log In
  • Register
No Result
View All Result
Irish Pharmacy News

Management and Treatment of Eye Conditions

IPN by IPN
22 October 2020
in Features, Learning
0
Management and Treatment of Eye Conditions
Previous Post

Minister for Health to introduce range of affordable healthcare measures next month

 Next Post

Paul Reid Named As New IPHA President
Next Post
Paul Reid Named As New IPHA President

Paul Reid Named As New IPHA President

Théa Pharma: Innovation, Partnership, and Leadership in Irish Eye Care

Théa Pharma: Innovation, Partnership, and Leadership in Irish Eye Care

13 October 2025
Leading Eye Experts Present Clinical Insights and Integrated Models of Care at National Eye Care Conference

Leading Eye Experts Present Clinical Insights and Integrated Models of Care at National Eye Care Conference

13 October 2025
Irish Pharmacy Union Welcomes Publication of the Community Pharmacy Agreement 2025

Budget 2026 Expands Access to Buprenorphine and Inclusion Health Services

13 October 2025

RECOMMENDED NEWS

A third of people with Dementia don’t have access to services

A third of people with Dementia don’t have access to services

2 years ago
Eczema

Clinical Updates in Eczema Care

1 year ago
peoples pharmacist

Finalists Announced: The People’s Pharmacist 2023, in association with Panadol

2 years ago
Astellas Receives Positive CHMP Opinion for XTANDITM (enzalutamide) for Patients with Metastatic Hormone-Sensitive Prostate Cancer

Astellas Receives Positive CHMP Opinion for XTANDITM (enzalutamide) for Patients with Metastatic Hormone-Sensitive Prostate Cancer

4 years ago
Tweets by Irish_PharmNews

Quick links

  • About
  • Advertise
  • Careers
  • Contact us

Other info

  • Contact us
  • Register for Digital Magazines
  • Privacy Policy
  • About
  • Advertise
  • Careers
  • Contact us

© 2024 IPN

  • Login

    Forgot password? | Register

    Register

    Registration confirmation will be emailed to you.

    Login | Forgot password?

    Reset Password

    Please enter your username or email address. You will receive a link to create a new password via email.

    Login

Login

Register

Forgotten Password?

Register | Lost your password?
| Back to Login
No Result
View All Result
  • News
  • Learning
  • Other
    • Conferencing
    • Developments
    • Product News
    • Profiles
    • Research
  • Digital Magazines (IPN Online Issues Older Issue Tabs)
  • Awards

© 2024 IPN